Alex Soto-Guterrez, Associate Professor in the department of Pathology and and co-director of the Human Liver Synthetic Biology Core of the PLRC along with Alina OstrowskaRodrigo Machado-Florentino and others published a review article in Seminars in Liver Disease entitled, “From a Single Cell to a Whole Human Liver: Disease Modeling and Transplantation”. PMID: 36044927 DOI: 10.1055/a-1934-5404

Full text link: click HERE


Although the underlying cause may vary across countries and demographic groups, liver disease is a major cause of morbidity and mortality globally. Orthotopic liver transplantation is the only definitive treatment for liver failure but is limited by the lack of donor livers. The development of drugs that prevent the progression of liver disease and the generation of alternative liver constructs for transplantation could help alleviate the burden of liver disease. Bioengineered livers containing human iPSC-derived liver cells are being utilized to study liver disease and to identify and test potential therapeutics. Moreover, bioengineered livers containing pig hepatocytes and endothelial cells have been shown to function and survive after transplantation into pig models of liver failure providing pre-clinical evidence toward future clinical applications. Finally, bioengineered livers containing human iPSC-derived liver cells have been shown to function and survive after transplantation in rodents but require considerable optimization and testing prior to clinical use. In conclusion, bioengineered livers have emerged as a suitable tool for modeling liver diseases and as a promising alternative graft for clinical transplantation. The integration of novel technologies and techniques for the assembly and analysis of bioengineered livers will undoubtedly expand future applications in basic research and clinical transplantation.